Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BOSC when you do DD you know what you own for the long term
B.O.S. Reports Third Quarter Revenue Growth of 6.7%; Net Income Increases by 63.6%
MICT will have C.C next week, I guess they will refer it. stock is up 85% now
Also CE Mark is another Milestone pre commercialization. GE EalthCare backing them all the way and a few thinks they might buy them out at some point. MC is still a total joke ,about $24m.
Dec. Data is an update, its not a material event, but people and inst. Looking forward towards commercialization in H1 2019, Company recently Re- Confirmed it.
Their Product might save Billions to Healthcare industry. CTO : "To remind our listeners, MRIs cost around $2 million to acquire and it weighs several tons and a liver scan takes about 20 minutes. They're only about 30,000 MRI systems in the world today compared to over a million ultrasound and about half of the MRIs are concentrated in the U.S. and Japan. Said another way most people in the world don't have easy access to MRI."
ER was good, but People have lost confidence, it seems due to concern about the merger with BNN.
Treasuries yeild moving down past days, time to to start loading stocks again? https://www.cnbc.com/quotes/?symbol=US30Y
But. A deal that could make an end to this Trade War might change the whole picture
https://twitter.com/_stealthtrader/status/1063379780735836161?s=19
I have been talking a lot about Trade War risks ( Boomernag effect) and was completely right. It seems, we are already in a Bear Market but Trump could surprise us again and make an end to this trade War any-time. If you remember, I also mentioned a recession possibility when no one talked about it , now many are talking about it too.
Please check here https://www.investopedia.com/trading/warrants-risky-but-high-return-investment-tool/
Tradable like Commons.
Bingo
MTH4, you have described it well. Not sure if I have something else to add. During Bear Market, it hards to predict which way the stock moves. Even solid Companies could tank, but if you are doing good DD, you can usually predict well, for the mid-long term.
Bear Market. Anyone sees a possible reversal at some point?
Put these micro caps in your Watch-list. Very cheap, low Burn. They will pop when you least expect it
$AYTU trading a half Cash on hand. Catalysts. Burn dropped by 40%, Revenues surges $PTIE had solid news today. trading under Equity. $SBOT Cash in hand+ short term investments above $2/sh.
$SBOT $AYTU trading a half Cash on hand. Catalysts. $PTIE had solid news today. trading under Equity. These low float companies are very cheap. low burn ( aytu burn dropped by 40%). They will pop when you least expect it
$S
PTIE Pain Therapeutics Appeals FDA Decision on REMOXY http://www.globenewswire.com/news-release/2018/11/12/1649568/0/en/Pain-Therapeutics-Appeals-FDA-Decision-on-REMOXY.html
Btw. most authors are mostly wrong most of the time. That's why you should never buy/sell based on these opinions especially when you can not verify if they are in long or short position. Always do your own DD too
Maybe that's the reason DTEA refused to talk about it that day, but with/without CBD, it worth not less than $640m, based on purchase prices Unilever paid past year for 2 Tea Makers Companies which had worse balance sheet.they paid 4 times revenues per estimations, $160m for Pukka which did only $40m, DTEA doing X4, and has no competition in Canada. Company doing X10 revenues than TLRY, Net Assets X3, Cash on Hand X2. Every economist will confirm based on current Net Assets that share price is higly undervalued.
just hired 2 people who work and are directors of Cannabis Company, and CEO commented past earnings a month ago:
Herschel Segal: "we have made adjustments at head office to change our operations and our culture. We are building a strong team and we have put more senior leaders in buying, marketing and product development. We are also paying more attention to our costs. As well, we are ready to find a CEO who will enthusiastically adapt to the DAVIDsTEA environment, lead with a realistic optimism and bring vision that will be refined and further developed with the senior executive team and the company's board".
Owner avg. purchase price is $21.4 and still holding all. There is a solid reason why. he is waiting the bid deal. Im holding for $20-$25/sh the long term. Days will tell.
Btw, you own shares, long/short or just hoping to get some on better price?
O.k found it. Wow.
Scarborough Eddie, is so right. I basically came to same conclusion, read my previous post. Is he commented to this article? I can't see his comments.do you have a link?
Thanks for sharing.Fits my DD about DTEA: I also mentioned that Unilever acquired Pukka for about $160m(est. 4 times sales as mentioned in your article).Pukka was doing $39m, DTEA doing X4. thats should be $640m. Co. has $90m Net Assets, $40M Cash. Immediate valuation per this alone is about $3.6/sh ($90m/25m O/S).
If Put CBD in their Tea, theoretically should be trading $100B, doing X10 Rev than $TLRY, net assets X3 either. Cash X2, MC only $55m.
they are already well settled and no marketing issue, 240 corp stores 450 Loblaws.
New CEO will be announced any time soon. CEO commented (Q2 Transcript a month ago) :
"we have made adjustments at head office to change our operations and our culture". "we are ready to find a CEO...just hired 2 ppl who work and are directors of Cannabis Co. One is Anne Darche.
Ms. Darche serves as a Director of Groupe Germain Inc. and 48North Cannabis Corporation.
Btw, CEO owns 46% at an average porchase price of $21.1/sh. he hasn't sold even a single share . I believe it could be a life changer investment.
they have a term on 5 years ( until 2022), you can trade them exactly like commons. all details here: http://investors.endrainc.com/prviewer/release_only/id/2560286
I would wait until data (Early December) bc on good data, it could run to $10 as this analyst sees https://www.analystsbuzz.com/2018/11/aytu-bioscience-aytu-to-strike-10-in-short-term-period/
link back to ER, Cash burn rate dropped hard and revenues surges.
3 weeks to data.
agree. ppl not doing DD, insiders getting all cheap shares.
ty. dropping 15% on no news.
NDRA Data should be great otherwise they would not participating in events in Basel, Geneva, San Francisco and Chicago, all of these In November and simultaneity presents bad data, it simply has no sense. inst. buying and MC is really cheap, only $24m, relating the market for TAEUS.
looking good bro.will participate in events in Basel, Geneva, San Francisco and Chicago, all of these In November + company just confirmed, data: "no later than December of this year"
The market for TAEUS is outrageously large. I don't think many grasp it yet. $24M MC. X10 2019.
No more Uncertainty. 3 huge conferences in November, and company just confirmed, data: "no later than December of this year"
NDRA
NDRAW on heavy accumulation Past days. it usually means a lot (Heads up )
right. Cash on hand alone about twice Market cap. 3 weeks to data. cash burn rate Reduced by 40%, from $4.5m to only $2.7m. cash on hand should be sufficient for 2 years!. Reminder: both insiders and inst. been buying bigly recently . insiders alone bought 1.5m+ shares + a new stake.
Good ER. Cash burn dropped by 40% first time!. AYTU defiantly moving forward is much more solid way. I'm holding mine and waiting for upcoming catalyst. I don't have a PT but I believe based on Market potential and revenues that share price should be much higher
TLRY +30%. DTEA no competition in Canada. Unilever acquired Pukka for about $160m(est. 4 Times sales). DTEA doing X4 ($40m/Qtr, or $160m Annually), that's $640m respectively vs $60M Market cap!. has $90m Net Assets, $40M Cash. DTEA has almost twice TLRY's ($13B cap) cash on hand, doing X10 Revenues Annually and Net Assets X3 either...."we are ready to find a CEO who will enthusiastically adapt to the DAVIDsTEA environment" "we have made adjustments at head office to change our operations and our culture", just hired 2 ppl who work and are directors of Cannabis Co.
when the "move" is done, you are looking at 20$/ stock because they are already well settled and no marketing issue. with $39 million cash , $20 million line of credit , 240 corp stores 450 Loblaws.
TLRY +30% vs DTEA no competition in Canada... Unilever acquired Pukka for about $160m(est. 4 Times sales). DTEA doing X4 ($40m/Qtr, or $160m Annually), that's $640m respectively vs $60M Market cap!. has $90m Net Assets, $40M Cash. DTEA has almost twice TLRY's ($13B cap) cash on hand, doing X10 Revenues Annually and Net Assets X3 either...."we are ready to find a CEO who will enthusiastically adapt to the DAVIDsTEA environment" "we have made adjustments at head office to change our operations and our culture", just hired 2 ppl who work and are directors of Cannabis Co.
when the "move" is done, you are looking at 20$/ stock because they are already well settled and no marketing issue. with $39 million cash , $20 million line of credit , 240 corp stores 450 Loblaws.
Uncertainty relating Economy, Stock Market... https://www.vox.com/midterm-elections/2018/11/7/18071344/trump-tax-returns-house-democrats-midterm
First, let's see ER ,then I will be able to re- confirmed my thoughts
Agree.
The last 4 times this guys called a PT, it got reached. Bullish hard on AYTU https://seekingalpha.com/instablog/49332322-paul-samuelson/5232899-aytu-bioscience-inc-release-promising-financial-shortly
i'm sharing it here because this is a great find. DTEA
i posted this a couple weeks ago, but worth a look if u haven't seen already: 2 separate interviews with CEO of Aphria $APH.TO $APHQF where he mentions $DTEA 7:10 mark: https://t.co/bypCJ9xwVV … 9:39 mark: https://t.co/OdAMEkFadJ … Coincidence, or a relationship coming?
— Find Alpha (@MicrocapTrader) November 6, 2018
Aytu BioScience Receives $5M Investment
That's half of current Market cap.